These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 34518377)
1. The Bihormonal Bionic Pancreas Improves Glycemic Control in Individuals With Hyperinsulinism and Postpancreatectomy Diabetes: A Pilot Study. Rayannavar A; Mitteer LM; Balliro CA; El-Khatib FH; Lord KL; Hawkes CP; Ballester LS; Damiano ER; Russell SJ; De León DD Diabetes Care; 2021 Nov; 44(11):2582-2585. PubMed ID: 34518377 [TBL] [Abstract][Full Text] [Related]
2. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348 [TBL] [Abstract][Full Text] [Related]
3. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709 [TBL] [Abstract][Full Text] [Related]
4. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. Russell SJ; El-Khatib FH; Sinha M; Magyar KL; McKeon K; Goergen LG; Balliro C; Hillard MA; Nathan DM; Damiano ER N Engl J Med; 2014 Jul; 371(4):313-325. PubMed ID: 24931572 [TBL] [Abstract][Full Text] [Related]
5. The use of CGM to identify hypoglycemia and glycemic patterns in congenital hyperinsulinism. Gariepy M; Yoosefi N; Silva C; Chanoine JP; Abdulhussein FS J Pediatr Endocrinol Metab; 2023 Dec; 36(12):1133-1139. PubMed ID: 37988593 [TBL] [Abstract][Full Text] [Related]
6. Clustering of Hypoglycemia Events in Patients With Hyperinsulinism: Extension of the Digital Phenotype Through Retrospective Data Analysis. Worth C; Harper S; Salomon-Estebanez M; O'Shea E; Nutter PW; Dunne MJ; Banerjee I J Med Internet Res; 2021 Oct; 23(10):e26957. PubMed ID: 34435596 [TBL] [Abstract][Full Text] [Related]
7. Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis- Related Diabetes. Sherwood JS; Castellanos LE; O'Connor MY; Balliro CA; Hillard MA; Gaston SG; Bartholomew R; Greaux E; Sabean A; Zheng H; Marchetti P; Uluer A; Sawicki GS; Neuringer I; El-Khatib FH; Damiano ER; Russell SJ; Putman MS Diabetes Care; 2024 Jan; 47(1):101-108. PubMed ID: 37874987 [TBL] [Abstract][Full Text] [Related]
8. Automated glycemic control with the bionic pancreas in cystic fibrosis-related diabetes: A pilot study. Sherwood JS; Jafri RZ; Balliro CA; Zheng H; El-Khatib FH; Damiano ER; Russell SJ; Putman MS J Cyst Fibros; 2020 Jan; 19(1):159-161. PubMed ID: 31420176 [TBL] [Abstract][Full Text] [Related]
9. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial. Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663 [TBL] [Abstract][Full Text] [Related]
10. Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study). Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Pehrsson NG; Moström P J Diabetes Sci Technol; 2016 May; 10(3):754-61. PubMed ID: 27081191 [TBL] [Abstract][Full Text] [Related]
11. Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Russell SJ; El-Khatib FH; Nathan DM; Magyar KL; Jiang J; Damiano ER Diabetes Care; 2012 Nov; 35(11):2148-55. PubMed ID: 22923666 [TBL] [Abstract][Full Text] [Related]
12. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study. Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006 [TBL] [Abstract][Full Text] [Related]
13. Continuous Glucose Monitoring Systems: Are They Useful for Evaluating Glycemic Control in Children with Hyperinsulinism? Rayannavar A; Elci OU; Mitteer L; De León DD Horm Res Paediatr; 2019; 92(5):319-327. PubMed ID: 32208390 [TBL] [Abstract][Full Text] [Related]
14. Continuous Glucose Monitoring for the Detection of Hypoglycemia in Patients With Diabetes of the Exocrine Pancreas. Shivaprasad C; Gautham K; Shah K; Gupta S; Palani P; Anupam B J Diabetes Sci Technol; 2021 Nov; 15(6):1313-1319. PubMed ID: 33322930 [TBL] [Abstract][Full Text] [Related]
15. Continuous Glucose Monitoring in Patients with Type 1 Diabetes and Impaired Awareness of Hypoglycemia: Also Effective in Patients with Psychological Distress? van Beers CAJ; de Wit M; Kleijer SJ; Geelhoed-Duijvestijn PH; DeVries JH; Kramer MHH; Diamant M; Serné EH; Snoek FJ Diabetes Technol Ther; 2017 Oct; 19(10):595-599. PubMed ID: 28836833 [TBL] [Abstract][Full Text] [Related]
16. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes. Rodbard D Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879 [TBL] [Abstract][Full Text] [Related]
17. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial. Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L; Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775 [TBL] [Abstract][Full Text] [Related]
18. Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home. Renard E; Farret A; Kropff J; Bruttomesso D; Messori M; Place J; Visentin R; Calore R; Toffanin C; Di Palma F; Lanzola G; Magni P; Boscari F; Galasso S; Avogaro A; Keith-Hynes P; Kovatchev B; Del Favero S; Cobelli C; Magni L; DeVries JH; Diabetes Care; 2016 Jul; 39(7):1151-60. PubMed ID: 27208331 [TBL] [Abstract][Full Text] [Related]
19. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781 [TBL] [Abstract][Full Text] [Related]
20. Feasibility of a bihormonal closed-loop system to control postexercise and postprandial glucose excursions. Van Bon AC; Jonker LD; Koebrugge R; Koops R; Hoekstra JB; DeVries JH J Diabetes Sci Technol; 2012 Sep; 6(5):1114-22. PubMed ID: 23063038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]